StockData

Amphastar Pharmaceuticals, Inc. (AMPH) stock

AMPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3013% below fair value
$29.10−0.07 (-0.24%)

Close on Nov 17, 2026Market cap $1.24BP/E 17.1Yield –

Amphastar Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Amphastar Pharmaceuticals's price to sales ratio was 1.7× on Nov 11, 2026, against 1.8× a year earlier. Over the last 5 years it ranged from 1.2× to 5.6×, with a median of 3.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.7×−0.0
2025Dec 31, 20251.7×−0.8
2024Dec 31, 20242.5×−2.4
2023Dec 29, 20234.9×+2.1
2022Dec 30, 20222.8×+0.1
2021Dec 31, 20212.7×−0.1
2020Dec 31, 20202.8×+0.1
2019Dec 31, 20192.8×−0.7
2018Dec 31, 20183.5×−0.2
2017Dec 29, 20173.6×+0.5
2016Dec 30, 20163.2×+0.4
2015Dec 31, 20152.8×+0.3
2014Dec 31, 20142.5×–

More Amphastar Pharmaceuticals figures

See a number that looks wrong?